formaldehyde and plx4032

formaldehyde has been researched along with plx4032 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, S; Demartin, K; Halait, H; Hillman, G; Langland, R; Lawrence, HJ; Shah, S; Soviero, S; Wu, L1
Anderson, S; Bloom, KJ; Dugan, MC; Halait, H; Kovach, B; Langland, R; Lawrence, HJ; Lee, JR; Meldrum, C; Ochoa, P; Rueschoff, J; Schilling, R; Vallera, DU1
Guldberg, P; Hager, H; Hansen, LL; Kristensen, LS; Lade-Keller, J; Riber-Hansen, R; Rømer, KM; Steiniche, T1
Huebner, C; Lloydd, R; Weber, R1

Trials

1 trial(s) available for formaldehyde and plx4032

ArticleYear
Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.
    Archives of pathology & laboratory medicine, 2012, Volume: 136, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; DNA Mutational Analysis; Female; Formaldehyde; Humans; Indoles; Male; Melanoma; Middle Aged; Mutation, Missense; Paraffin Embedding; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sulfonamides; Tissue Fixation; Vemurafenib; Young Adult

2012

Other Studies

3 other study(ies) available for formaldehyde and plx4032

ArticleYear
Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma.
    Diagnostic molecular pathology : the American journal of surgical pathology, part B, 2012, Volume: 21, Issue:1

    Topics: Cell Line, Tumor; DNA Mutational Analysis; DNA, Neoplasm; Formaldehyde; Humans; Indoles; Melanoma; Mutation; Paraffin Embedding; Patient Selection; Predictive Value of Tests; Proto-Oncogene Proteins B-raf; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Skin Neoplasms; Sulfonamides; Tissue Fixation; Vemurafenib

2012
Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
    The Journal of molecular diagnostics : JMD, 2013, Volume: 15, Issue:1

    Topics: DNA Mutational Analysis; Female; Formaldehyde; Humans; Indoles; Male; Melanoma; Mutation; Paraffin Embedding; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Skin Neoplasms; Sulfonamides; Vemurafenib

2013
A HRM assay for identification of low level BRAF V600E and V600K mutations using the CADMA principle in FFPE specimens.
    Pathology, 2017, Volume: 49, Issue:7

    Topics: Antineoplastic Agents; DNA Mutational Analysis; Formaldehyde; Humans; Indoles; Melanoma; Mutation; Paraffin Embedding; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Skin Neoplasms; Sulfonamides; Tissue Fixation; Vemurafenib

2017